| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/11/2002 | WO2001066745A3 Presenilin/crk binding polypeptides (pcbp) and methods of use thereof |
| 07/11/2002 | WO2001059094A3 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 07/11/2002 | WO2001054813A8 Devices and methods for biochip multiplexing |
| 07/11/2002 | WO2001050847A3 Reca / rad51 recombinase-mediated production of recombinant organisms |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001044478A9 CORE 1 β3-GALACTOSYL TRANSFERASES AND METHODS OF USE THEREOF |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001042510A3 Method for selectively isolating a nucleic acid |
| 07/11/2002 | WO2001040516A3 Generation of single-strand circular dna from linear self-annealing segments |
| 07/11/2002 | WO2001040476A3 Bacillus thuringiensis toxin active against formicidae (ant) |
| 07/11/2002 | WO2001036473A3 Human g protein-coupled receptors |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2001031580A3 Methods and devices for identifying patterns in biological systems |
| 07/11/2002 | WO2001031037A3 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | WO2001027632A3 Cellular receptor mutations predicted by multiple-sequence-allignment |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001020018A3 Diagnosing and treating arthritic disorders |
| 07/11/2002 | WO2001019981A3 Functional genomics using zinc finger proteins |
| 07/11/2002 | WO2001019857A3 Facilitative transporter (ft1 and ft2) from drosophila melanogaster and uses thereof |
| 07/11/2002 | WO2001016323A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001014573A9 Duplicated cassava vein mosaic virus enhancers and uses thereof |
| 07/11/2002 | WO2001012816A3 Porcine endovirus gag and env and diagnostic uses thereof |
| 07/11/2002 | WO2001012809A3 Heterodimeric vegf variants used for inhibiting angiogenesis |
| 07/11/2002 | WO2001012802A9 Random mutagenesis and amplification of nucleic acid |
| 07/11/2002 | WO2001011335A9 Antiviral compounds that inhibit viral replication |
| 07/11/2002 | WO2001011087A3 Method of evaluating a gene transfer vector and gene transfer vector product interactions |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001011081A3 Microbial polynucleotides expressed during infection of a host |
| 07/11/2002 | WO2001011035A9 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 07/11/2002 | WO2001010907A9 Therapeutic polypeptides and methods for using same |
| 07/11/2002 | WO2001010896A3 Factor x analog with an improved ability to be activated |
| 07/11/2002 | WO2001007665A9 Sequence determination of nucleic acids using electronic detection |
| 07/11/2002 | WO2001007661A3 Polynucleotide amplification method |
| 07/11/2002 | WO2001006016A9 Amplification of nucleic acids with electronic detection |
| 07/11/2002 | WO2000078996A9 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000067016A9 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 07/11/2002 | WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061816A9 Electronically mediated nucleic acid amplification in nasba |
| 07/11/2002 | WO2000061747A9 Clasp-2 transmembrane proteins |
| 07/11/2002 | WO2000060118A3 Electrophoretic analysis of target molecules using adapter molecules |
| 07/11/2002 | WO2000058472A9 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 07/11/2002 | WO2000053812A3 Replica amplification of nucleic acid arrays |
| 07/11/2002 | WO2000052187A9 Enhanced system for construction of adenovirus vectors |
| 07/11/2002 | WO2000049937A9 Trpm-2 antisense therapy |
| 07/11/2002 | WO1999061581A3 Sphingosine kinase, cloning, expression and methods of use |
| 07/11/2002 | US20020092041 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants. |
| 07/11/2002 | US20020092040 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1, 4 glucans in plants, fungi and microorganisms |
| 07/11/2002 | US20020092039 Methods for producing carotenoid compounds and specialty oils in plant seeds |
| 07/11/2002 | US20020092038 Transgenic plant for use in the generation of lubricants, foods and vegetable oils |
| 07/11/2002 | US20020092037 Culturing plant cells on a support membrane; obtain solid support, incubate with plant cells, monitor plant cell propagation |
| 07/11/2002 | US20020092036 Plant for use as tool in the generation of heterologous proteins |
| 07/11/2002 | US20020092035 Cell cultures for use in monitoring preferential gene expression in cells |
| 07/11/2002 | US20020092034 Non-human model of gestational and adult folate deficiency and uses thereof |
| 07/11/2002 | US20020092033 Turn animal bladder into a bioreactor, for gene expression of any exogenous biomolecule such as blood clotting factors, hormones; also animal models of bladder cancer; easy to purify from urine |
| 07/11/2002 | US20020091666 Method and system for modeling biological systems |
| 07/11/2002 | US20020091664 Methods for measuring therapy resistance |
| 07/11/2002 | US20020091249 Human tumor suppressor polypeptides |
| 07/11/2002 | US20020091248 Nucleotide sequences coding polypeptide for use in the treatment of Bardet-Biedl Syndrome, hearing loss, retinis pigmentosa, obesity, hypogonadism, diabetes and cardiovascular disorders |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091245 Process for immobilization of nucleic acid molecules on a substrate |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091238 Nuclelotide sequences coding transport protein for use in treatment of cancer, pain, aberrant cellular proliferation and/or differentiation, hormonal and liver disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091235 St - B17 serotonin receptor |
| 07/11/2002 | US20020091096 Nucleic acid, including DNA, immunization against disease caused by infection by a strain of Chlamydia employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia |
| 07/11/2002 | US20020091095 Modulation of Fas and FasL expression |
| 07/11/2002 | US20020091094 Glutamic acid decarboxylase (GAD) based delivery system |
| 07/11/2002 | US20020091084 Human calcineurin B-like protein (CAB) and polynucleotides which identify and encode CAB. |
| 07/11/2002 | US20020091079 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2002 | US20020090729 System and method for treatment of samples on solid supports |
| 07/11/2002 | US20020090726 Expression cassette and plasmids for a guard cell specific expression and their use for the introduction of transgenic plant cells and plants |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090723 Generating preferential cell cultures; isolate blastocyst, culture, recover cells |
| 07/11/2002 | US20020090722 Pluripotent mammalian cells |
| 07/11/2002 | US20020090721 Mucin-containing delivery vehicle for the transport of biomolecules |
| 07/11/2002 | US20020090719 Expression vectors containing hybrid ubiquitin promoters |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090716 EHV-1 vectors |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090714 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 07/11/2002 | US20020090713 Heat-stable D-aminoacylase |
| 07/11/2002 | US20020090707 Promoter sequences |
| 07/11/2002 | US20020090705 62088, a novel human nucleoside phosphatase family member and uses thereof |
| 07/11/2002 | US20020090704 Sucrose phosphate synthase |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090701 14257 novel protein kinase molecules and their uses therefor |
| 07/11/2002 | US20020090699 27439, novel human hydroxylase and uses therefor |
| 07/11/2002 | US20020090698 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |